Surgery for Lung Cancer Gives IPF Patients Better Prognosis, Study Finds

Surgery is the most effective option to treat lung cancer in people with less severe idiopathic pulmonary fibrosis (IPF), a Korean study has found. For IPF patients who have a poorer prognosis (more advanced GAP stages), researchers recommend accounting for cancer clinical stage and estimated tolerability…

Lung Cancer in IPF Patients Best Treated on ‘Do No Harm’ Basis, Commentary Argues

The management of patients with idiopathic pulmonary fibrosis (IPF) and lung cancer should follow the premise “first, do no harm,” researchers argue in the journal The Lancet Respiratory Medicine. Their commentary, “Patients with IPF and lung cancer: diagnosis and management,” spotlights the fact that — despite lung…

Antibody Preventing Radiation-Triggered Lung Fibrosis May Improve Cancer Treatment

An antibody that protects against radiation-induced lung fibrosis could improve the treatment of cancers that stem from radiation damage to the lungs, according to a study. The research demonstrated that an antibody against connective tissue growth factor, or CTGF,  prevented pulmonary fibrosis in up to 80 percent of irradiated mice. Those…

Children Treated for Cancer at Higher Risk of Pulmonary Fibrosis as Adults

Childhood cancer survivors are at an increased risk of developing lung fibrosis for up to 25 years after their initial cancer diagnosis, analyses of data from the Childhood Cancer Survivor Study show. The report, “Risk and impact of pulmonary complications in survivors of childhood cancer: A report from the Childhood…